Analysis of the situation of cervical cancer in the Region of the Americas - Executive Summary

Overview

This document is the executive summary of the technical report Analysis of the situation of cervical cancer in the Region of the Americas (available in Spanish at the moment). 

Cervical cancer is a preventable disease through vaccination against the human papillomavirus (HPV) and the detection and treatment of precancerous lesions.
Despite its preventable nature, it remains a significant cause of cancer death in women, especially in low- and middle-income countries. To prevent and control
this disease, in September 2018, the 56th Directing Council of the Pan American Health Organization (PAHO) approved the Plan of Action for the Prevention and
Control of Cervical Cancer 2018-2030. The main objective of this Plan is to help Member States develop comprehensive cervical cancer control programs. In 2020,
the World Health Organization (WHO) launched a strategy to accelerate the elimination of cervical cancer as a public health problem, with specific targets for
vaccination, screening, and treatment. To achieve this goal, the Strategy proposes three objectives for countries by 2030: 90% coverage of HPV vaccination in girls
(by age 15); 70% screening coverage (70% of women undergo high-performance tests at ages 35 and 45); 90% treatment of precancerous lesions and management of 90% of invasive cancer cases.

Learn more about the Strategy to Accelerate the Elimination of Cervical Cáncer